Spots Global Cancer Trial Database for An Extension Study of Linifanib (ABT-869) in Subjects With Advanced or Metastatic Solid Tumors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: An Extension Study of Linifanib (ABT-869) in Subjects With Advanced or Metastatic Solid Tumors
Official Title: An Extension Study of Linifanib in Subjects With Advanced or Metastatic Solid Tumors
Study ID: NCT01413893
Conditions
Interventions
Study Description
Brief Summary: An extension study of linifanib in subjects with advanced or metastatic solid tumors.
Detailed Description: This study is designed to evaluate the safety of linifanib in subjects with advanced or metastatic solid tumors.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Contact Details
Name: Mark D. McKee, MD
Affiliation: Abbott
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
